KFDA allows restricts use of Avandia diabetes drug

Published: 2010-11-04 07:00:00

Updated: 2010-11-04 07:00:00

The Korea Food and Drug Administration says that it would impose new restrictions on the use of the diabetes drug Avandia in an effort to protect patients from the risks of cardiovascular problems.

The restrictions will require patients to sign documents indicating they are aware of the risks ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK